Sumalinog, Ruvelyn Q.

HRN: 29-34-50  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2026
CEFTRIAXONE 1G (VIAL)
07/25/2026
08/01/2026
IV
2G
OD
PNEUMONIA
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: